Career Enhancement Program (CEP) Awardees
| Vishal Chandra, PhD | Assistant Professor, OBGYN, Oklahoma University | Targeting Obesity and Progesterone Resistance in Endometrial Cancer |
| Deirdre Hill, PhD | Research Associate Professor, Internal Medicine, University of New Mexico | Assessing etiology and survival by Endometrial Cancer histology |
| Jason Weber, PhD | Professor, Medicine – Molecular Oncology, Washington University | Identifying a new IFN pathway vulnerability in serous-like endometrial cancer |
| John Krais, PhD | Assistant Professor, Oncology, Washington University | Targeting altered DNA damage signaling in endometrial cancer |
| Kelly Bolton, MD PhD | Assistant Professor, Oncology, Washington University | Impact of Weight Loss on the Endometrial Cancer Mutational Landscape |
| Shailendra Dwivedi, PhD | Assistant Professor, Pathology, Oklahoma University | Biomarkers and Therapeutic Targets in Uterine Carcinosarcoma: The Role of Extracellular Vesicles and the Tumor Microenvironment |
| Rajani Rai, PhD | Assistant Professor, OBGYN, Oklahoma University | Targeting Obesity-Driven Endometrial Cancer |
| Robert Lake, PhD | Research Assistant Professor, Internal Medicine, University of New Mexico | Targeting epigenetic regulators to treat p53 gain-of-function driven endometrial cancer |
Career Enhancement Program Directors
Developmental Research Program (DRP) Awardees
| Lindsay Kuroki, MD | Associate Professor, OBGYN, Washington University | Molecular classification of early stage endometrial cancer: Prognosis and treatment efficacy a GOG-249 Ancillary Study |
| Bethany Hannafon, MD | Assistant Professor, OBGYN, University of Oklahoma | Targeting Immunometabolism and Inflammation-Mediated Immune Escape in Endometrial Cancer |
| Hua-Ying Fan, PhD | Associate Professor, Internal Medicine, University of New Mexico | Repurposing Auranofin: A Novel Notch Pathway Inhibitor in Endometrial Cancer Therapy |
| Paul DeAngelis, PhD | Professor, Physiology and Biochemistry, University of Oklahoma | Next-Generation Heparanase Inhibitors for Treatment of Endometrial Cancer |
| Mary M. Mullen, MD | Assistant Professor, OBGYN, Washington University | HER2 expression in early stage endometrial cancer: Ancillary analysis of GOG-0249 |
| Quing Zhu, PhD | Edwin H. Murty Professor of Engineering, Biomedical Engineering, Washington University | Non-invasive, high resolution, subsurface imaging of the endometrial cavity for cancer detection and diagnosis |
| Mara Steinkamp, PhD | Associate Professor, Pathology, University of New Mexico | Testing macrophage repolarization agents in autologous humanized models of endometrial cancer |
| Priyanka Verma, PhD | Assistant Professor, Oncology, Washington University | Defining new vulnerabilities in Fbxw7-mutated endometrial cancers |
| Liang Ma, PhD | Associate Professor, Dermatology, Washington University | Targeting SALL1 in endometrial cancer |
| Xiang Xue, PhD | Associate Professor, Biochemistry and Molecular Biology, University of New Mexico | Targeting endometrial cancer with novel ferroptosis-inducing curcumin analogues |
Developmental Research Program Directors
CEP/DRP Expectations and Opportunities
- Consistently attend SPORE meetings
- Present to the SPORE Internal and External Advisory Boards
- Present at least once per year at a Route 66 SPORE Monthly Meeting to receive feedback and guidance
- Fully develop and submit at least one extramural grant application, with guidance available from SPORE colleagues and CEP and DRP leadership
For the Career Enhancement Program
- Devote at least 25% of their time to translational endometrial cancer research (15% for established investigators)
- Attend at least one national SPORE meeting each year, as appropriate
- Present posters at the annual NCI Translational Science Meeting or equivalent